Eli Lilly Announces Insulin Price Cuts Amid Ongoing Criticism


Eli Lilly is announcing 70-percent price cuts on its most commonly prescribed insulin.  The move comes as Eli Lilly and other insulin makers face ongoing criticism about high prices driving some diabetics to ration the life-saving drug.  Starting in October, the price of a Humalog 100 units vial will be slashed to 66-dollars, down from two-hundred-seventy-four.  And Lilly, based in Indianapolis, says starting in May, it’ll cap out-of-pocket insulin costs at 35-dollars a month for people with insurance.  Eli Lilly and two foreign pharmaceutical companies with New Jersey headquarters, Novo Nordisk and Sanofi, control the insulin market.

***Courtesy of Total Traffic News***

Spread the word

Trending Now

Featured News Podcasts

Subscribe to our Community Newsletter

By submitting this form, you are consenting to receive marketing emails from: Prairie Communications, 55 Public Square, Monmouth, IL, 61462, https://977wmoi.com/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Choose a Category

Continue Reading